Overview

Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study

Status:
Completed

Trial end date:
2017-06-30

Target enrollment:

Participant gender:

Summary

- Purpose: The investigators aimed to investigate the safety and efficacy in the treatment of fecal incontinence by injection of ALLO-ASC into the anal sphincter. - Method 1. Safety test of allogenic ASCs injection 2. Efficacy test of allogenic ASCs injection

Phase:

Phase 1

Details

Lead Sponsor:

Yonsei University

Treatments:

Fibrin Tissue Adhesive